% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Michalowsky:141519,
      author       = {Michalowsky, Bernhard and Xie, Feng and Eichler, Tilly and
                      Hertel, Johannes and Rädke, Anika and Kilimann, Ingo and
                      Teipel, Stefan and Wucherer, Diana and Zwingmann, Ina and
                      Thyrian, Jochen René and Hoffmann, Wolfgang},
      title        = {{C}ost-effectiveness of a collaborative dementia care
                      management-{R}esults of a cluster-randomized controlled
                      trial.},
      journal      = {Alzheimer's and dementia},
      volume       = {15},
      number       = {10},
      issn         = {1552-5260},
      address      = {Amsterdam [u.a.]},
      publisher    = {Elsevier},
      reportid     = {DZNE-2020-07843},
      pages        = {1296-1308},
      year         = {2019},
      abstract     = {The purpose of this study was to determine the
                      cost-effectiveness of collaborative dementia care management
                      (DCM).The cost-effectiveness analysis was based on the data
                      of 444 patients of a cluster-randomized, controlled trial,
                      conceptualized to evaluate a collaborative DCM that aimed to
                      optimize treatment and care in dementia. Health-care
                      resource use, costs, quality-adjusted life years (QALYs),
                      and incremental cost per QALY gained were measured over a
                      24-month time horizon.DCM increased QALYs (+0.05) and
                      decreased costs (-569€) due to a lower hospitalization and
                      a delayed institutionalization (7 months) compared with
                      usual care. The probability of DCM being cost-effective was
                      $88\%$ at willingness-to-pay thresholds of 40,000€ per
                      QALY gained and higher in patients living alone compared to
                      those not living alone $(96\%$ vs. $26\%).DCM$ is likely to
                      be a cost-effective strategy in treating dementia and thus
                      beneficial for public health-care payers and patients,
                      especially for those living alone.},
      keywords     = {Aged / Cooperative Behavior / Cost-Benefit Analysis:
                      statistics $\&$ numerical data / Dementia: therapy / Disease
                      Management / Female / Humans / Male / Patient Acceptance of
                      Health Care: statistics $\&$ numerical data /
                      Quality-Adjusted Life Years / Surveys and Questionnaires},
      cin          = {AG Thyrian / AG Hoffmann / AG Teipel / AG Grabe},
      ddc          = {610},
      cid          = {I:(DE-2719)1510800 / I:(DE-2719)1510600 /
                      I:(DE-2719)1510100 / I:(DE-2719)5000001},
      pnm          = {344 - Clinical and Health Care Research (POF3-344)},
      pid          = {G:(DE-HGF)POF3-344},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:31409541},
      doi          = {10.1016/j.jalz.2019.05.008},
      url          = {https://pub.dzne.de/record/141519},
}